Aerovate Therapeutics discloses director purchase of $1.55M in common stock

In a regulatory filing, Aerovate Therapeutics disclosed that its director Rajeev Shah of RA Capital bought 928K shares of common stock on June 17th in a total transaction size of $1.55M. Shares of Aerovate Therapeutics are up 11.6% afterhours at $1.63.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue